Press Release

CREMER OLEO has become the holder of the first CEP ever granted for a Medium-Chain Triglyceride (MIGLYOL® 812 N).

Format: PDF file | Document type: Press Release | Promoted Content

This Press Release has been written by CREMER OLEO GmbH & Co. KG , and any views and opinions expressed do not necessarily reflect those of www.outsourcing-pharma.com

Cremer Oleo
Download PDF Now!

CREMER OLEO has gathered its activities for the pharmaceutical industry under the roof of CREMER Health, with a strong commitment to quality leadership in Oleoceuticals. 

Our pharmaceutical excipients for topical, oral and rectal applications as well as our oleo-chemical based active pharmaceutical ingredients for enteral and parenteral applications have been enjoying a good reputation for decades. 

Our strict adherence to quality is underpinned and rewarded with the repeated granting of an EU GMP-certificate as well as the availability of several regulatory documentations (US DMFs / CEP). 

Supplier info centre